Academic Research Drive CUH is a leading national centre for specialist treatment and a designated comprehensive biomedical research centre, as well as an academic health science centre. This makes it a strong partner for high end research equipment, data analytics for clinical trials, and partnerships that support advanced therapies such as stem cell and CAR-T programs. Ongoing NIHR funding for advanced therapies signals opportunities to present specialized laboratory and trial support solutions, service contracts, and integrated research infrastructure.
Cancer Centre Expansion CUH's cancer care ambitions include the Cambridge Cancer Research Hospital and faster access to diagnostics through self-referral improvements and cross-system partnerships. This creates sales opportunities in imaging and diagnostic equipment, radiology IT, AI-assisted image analysis, patient access and referral management systems, and workflow integrations with NHS care boards.
Leadership and Strategy Leadership transition with a new Chief Executive presents an opening to engage on strategic priorities such as sustainable, innovative care and growth through academic and clinical partnerships. Position offerings that align with leadership priorities such as digital transformation, efficiency gains, research collaboration, and patient-centered services, and target procurement, strategy, and research offices for long-term partnerships.
Sustainability Focus CUH's sustainability mandate signals a strong sustainability trajectory. Opportunities exist for energy and facilities management solutions, waste reduction and decarbonization programs, green procurement, and carbon reporting tools. Vendors can propose IoT-enabled monitoring, predictive maintenance, and lifecycle optimization for clinical assets.
Workforce and IT As a large Trust with a substantial workforce, CUH may require scalable workforce and IT enablement solutions. Potential opportunities include enterprise project and portfolio management, workforce scheduling and training platforms, secure collaboration tools, and patient engagement or self-service portals that integrate with existing NHS systems and the Cambridge cancer pathway.